首页> 美国卫生研究院文献>Biophysical Journal >Characterization of Interaction between Cationic Lipid-Oligonucleotide Complexes and Cellular Membrane Lipids Using Confocal Imaging and Fluorescence Correlation Spectroscopy
【2h】

Characterization of Interaction between Cationic Lipid-Oligonucleotide Complexes and Cellular Membrane Lipids Using Confocal Imaging and Fluorescence Correlation Spectroscopy

机译:共焦成像和荧光相关光谱法表征阳离子脂质寡核苷酸复合物和细胞膜脂质之间的相互作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Complexes formed by cationic liposomes and single-strand oligodeoxynucleotides (CL-ODN) are promising delivery systems for antisense therapy. ODN release from the complexes is an essential step for inhibiting activity of antisense drugs. We applied fluorescence correlation spectroscopy and confocal laser scanning microscopy to monitor CL-ODN complex interaction with membrane lipids leading to ODN release. To model cellular membranes we used giant unilamellar vesicles and investigated the transport of Cy-5-labeled ODNs across DiO-labeled membranes. For the first time, we directly observed that ODN molecules are transferred across the lipid bilayers and are kept inside the giant unilamellar vesicles after release from the carriers. ODN dissociation from the carrier was assessed by comparing diffusion constants of CL-ODN complexes and ODNs before complexation and after release. Freely diffusing Cy-5-labeled ODN (16-nt) has diffusion constant DODN = 1.3 ± 0.1 × 10−6 cm2/s. Fluorescence correlation spectroscopy curves for CL-ODN complexes were fitted with two components, which both have significantly slower diffusion in the range of DCL-ODN = ∼1.5 × 10−8 cm2/s. Released ODN has the mean diffusion constant D = 1.1 ± 0.2 × 10−6 cm2/s, which signifies that ODN is dissociated from cationic lipids. In contrast to earlier studies, we report that phosphatidylethanolamine can trigger ODN release from the carrier in the full absence of anionic phosphatidylserine in the target membrane and that phosphatidylethanolamine-mediated release is as extensive as in the case of phosphatidylserine. The presented methodology provides an effective tool for probing a delivery potential of newly created lipid formulations of CL-ODN complexes for optimal design of carriers.
机译:由阳离子脂质体和单链寡聚脱氧核苷酸(CL-ODN)形成的复合物是有前途的反义治疗传递系统。从复合物中释放ODN是抑制反义药物活性的重要步骤。我们应用了荧光相关光谱和共聚焦激光扫描显微镜来监测CL-ODN复合物与导致ODN释放的膜脂的相互作用。为了模拟细胞膜,我们使用了巨大的单层囊泡,并研究了Cy-5标记的ODN在DiO标记的膜上的转运。第一次,我们直接观察到ODN分子从脂质双层中转移出来,并从载体中释放后被保留在巨大的单层囊泡中。通过比较复合前和释放后CL-ODN复合物和ODN的扩散常数来评估ODN从载体的解离。自由扩散的Cy-5标记的ODN(16-nt)的扩散常数DODN = 1.3±0.1×10 -6 cm 2 / s。 CL-ODN配合物的荧光相关光谱曲线装有两个组分,在DCL-ODN =〜1.5×10 -8 cm 2 /秒。释放的ODN的平均扩散常数D = 1.1±0.2×10 −6 cm 2 / s,这表明ODN与阳离子脂质解离。与早期的研究相反,我们报道在目标膜中完全不存在阴离子磷脂酰丝氨酸的情况下,磷脂酰乙醇胺可以触发ODN从载体中释放,并且磷脂酰乙醇胺介导的释放与磷脂酰丝氨酸一样广泛。提出的方法学提供了一种有效的工具,用于探测新创建的CL-ODN复合物脂质制剂对载体的最佳设计的传递潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号